Shenzhen city Aabel Technology Development Co. Ltd., radionuclide labeling and drug preclinical pharmacokinetic research platform with the perfect quality assurance system, strict management and technical specification of experimental animal management practices, uphold the laboratory operation system standard, in order to promote the research and development of new drugs into clinical research results as soon as possible for the purpose, for domestic foreign pharmaceutical companies, drug R & D institutions and scientific research institutes and other professional and technical services to provide high quality and high efficiency.
Services include the following:
1. radionuclide labeling of biological macromolecules (125I);
Low energy radionuclide 14C labeling of 2. small molecule drugs;
Study on the chemical purity of 3., purity and specific activity of radioactive labeled drug and purification, quality control;
4. pharmacokinetics and biodistribution study of molecular imaging in vivo;
5. radioactive detection (molecular function, cellular uptake, RIA kit etc.)
6. clinical pharmacokinetics of whole animals according to CFDA requirement;
7. study on in vitro drug delivery characteristics based on enzyme kinetics and plasma protein binding.